Physician profile
Antonio M Granda
NPI 1780624023
$1,338.15
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2021: $136 · 2022: $361 · 2023: $256 · 2024: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,011.05 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $161.54 | 2019-2024 | Xifaxan, Trulance |
| Gilead Sciences, INC. | $51.32 | 2021 | |
| Merck Sharp & Dohme LLC | $39.92 | 2021 | |
| Capsovision, INC. | $23.58 | 2024 | Capsocam Plus |
| Qol Medical, LLC | $20.72 | 2023 | Sucraid |
| Pfizer INC. | $16.67 | 2024 | |
| Nestle Healthcare Nutrition INC. | $13.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Granda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.